Antithrombotic therapy in patients with ACS and atrial fibrillation: A challenge in clinical practice


Journal Article (Review)

Atrial fibrillation (AF) is the most commonly encountered cardiac arrhythmia in clinical practice. Furthermore, the incidence of AF steadily increases with advancing age, and AF is also a frequently diagnosed complication following ACS. The management of patients with AF and ACS who require triple therapy (currently defined as aspirin plus clopidogrel and warfarin) is challenging. The aim of this article is to review the risk-benefit trade-off between the ischemic and bleeding events that are associated with the various antithrombotic combination therapies used to treat this high-risk patient population.

Duke Authors

Cited Authors

  • Armaganijan, LV; Lopes, RD

Published Date

  • November 17, 2011

Published In

Volume / Issue

  • 10 / 3

Start / End Page

  • 97 - 102

Electronic International Standard Serial Number (EISSN)

  • 2040-3860

International Standard Serial Number (ISSN)

  • 1369-5312

Citation Source

  • Scopus